ARCHIVES

The Selling Begins: CT Offered Beyond High-Risk Group

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 26, 2006

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

Poll Finds Strong Support For Research; Yarbro Leads International Cancer Nurses.

October 6, 2000

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

March 21, 2008